Clinical Observation of Edaravone Combined with Citicoline Sodium in the Treatment of Acute Cerebral Infarction
10.6039/j.issn.1001-0408.2016.08.22
- VernacularTitle:依达拉奉联合胞磷胆碱钠治疗急性脑梗死的临床观察
- Author:
Qingjing TAN
;
Xing JI
;
Zhibin JIANG
;
Feng LU
;
Demin ZHANG
;
Linyu LI
;
Bo LI
- Publication Type:Journal Article
- Keywords:
Edaravone;
Citicoline sodium;
Drug combination;
Acute cerebral infarction;
Therapeutic efficacy;
Oxidative stress;
Inflammatory factors
- From:
China Pharmacy
2016;27(8):1081-1084
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the therapeutic efficacy of edaravone combined with citicoline sodium on acute cere-bral infarction and its effects on the levels of oxidative stress and inflammatory factors. METHODS:108 patients with acute cere-bral infarction were randomly divided into edaravone group(single group)and edaravone+citicoline sodium group(drug combina-tion group),with 54 cases in each group. Based on routine treatment,single group was given Edaravone injection 30 mg added in-to 100 ml 0.9% Sodium chloride injection intravenously,bid,used up within 30 min each time;drug combination group was addi-tionally given Citicoline sodium injection 0.5 g added into 250 ml 0.9% Sodium chloride injection intravenously,qd,on the basis of single group. Treatment course of 2 groups lasted for 2 weeks. NIHSS,HDS,Barthel index,oxidant stress indicator and inflam-matory factors were compared between 2 groups before and after treatment. RESULTS:After treatment,the effective rate of NI-HSS in drug combination group was 81.48%,which was significantly higher than single group(53.70%),with statistical signifi-cance (χ2=9.511,P=0.002). HDS score and Barthel index of 2 groups were significantly increased after treatment,especially in drug combination group,with statistical significance(P<0.05). Compared with before treatment,contents of MDA and ET-1 in 2 groups were decreased significantly,while SOD activity and NO content were increased significantly;the inflammatory cytokines IL-6,IL-8,IL-12 and IL-16,TNF-α were all decreased gradually,with statistical significance (P<0.05);the improvement of each indicator in drug combination group was more significant than single group,with statistical significance(P<0.05). CONCLU-SIONS:Edaravone combined with citicoline sodium show good therapeutic efficacy in the treatment of acute cerebral infarction, can decrease the levels of oxidative stress and inflammation and promote the recovery of the neurological function and the daily liv-ing ability.
